Related Experiment Videos
How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
1First Department of Internal Medicine, School of Medicine, Yokohama City University, Japan.
American Journal of Clinical Pathology
|November 1, 1991
Summary
Vitronectin binds to platelet receptors, potentially modulating blood clot formation. This study investigated vitronectin
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Vitronectin is an adhesive protein found in plasma and extracellular matrix.
- It shares the Arg-Gly-Asp sequence with other adhesive proteins, binding to integrin receptors.
- Platelet glycoprotein IIb-IIIa (GPIIb-IIIa) is an integrin known to bind vitronectin and other adhesive proteins.
Purpose of the Study:
- To investigate the interaction between vitronectin and platelet GPIIb-IIIa.
- To determine the mechanism and characteristics of vitronectin binding to platelets.
- To assess the functional impact of vitronectin on platelet aggregation.
Main Methods:
- Studied vitronectin binding to thrombin-stimulated platelets using calcium-dependent assays.
- Quantified binding affinity and receptor site density.
- Investigated inhibition of binding by other adhesive proteins, a specific peptide (Arg-Gly-Asp-Ser), and a monoclonal antibody (LJ-CP8).
- Assessed the effect of vitronectin and fibrinogen on thrombin-induced platelet aggregation.
Main Results:
- Vitronectin demonstrated specific, saturable, and calcium-dependent binding to activated platelets.
- Approximately 9,100 binding sites per platelet were identified with a molecular weight of 290 nmol/L.
- Binding was inhibited by other adhesive proteins, the Arg-Gly-Asp-Ser peptide, and an anti-GPIIb-IIIa antibody.
- Vitronectin inhibited platelet aggregation, while fibrinogen enhanced it.
Conclusions:
- Vitronectin binds to activated GPIIb-IIIa on platelets.
- Vitronectin may regulate platelet aggregation by competing with fibrinogen for GPIIb-IIIa binding.
- These findings suggest a role for vitronectin in modulating platelet function and thrombus formation.